Working with a biotinylated antibody: what the antibody biotin and streptavidin antibody system buys in signal amplification, why a biotin labeled antibody fails in tissues that contain biotin of their own, and how to block that first

Using the system properly

1. Understand where the amplification comes from. Several biotins are attached to each antibody and each can bind a streptavidin conjugate carrying several reporter molecules, so the signal multiplies at two stages. That is why the system rescues weak targets that direct conjugates cannot detect.
2. Block endogenous biotin in tissues that carry it. Liver, kidney, brain and several other tissues contain substantial free biotin. Without a blocking step using avidin followed by free biotin, those tissues stain regardless of the primary antibody, and the result looks like real staining.
3. Run the primary-free control in every tissue. The control that exposes endogenous biotin is the one with the detection system and no primary antibody. In a tissue you have not used before, that control is not optional and it costs one slide.
4. Watch the biotin in the sample and the medium. Culture media and serum supplements contain biotin, and samples from supplemented subjects can carry enough to interfere with an immunoassay. This is a known and documented source of erroneous immunoassay results and it is worth knowing about before an unexplained value appears.
5. Titrate both halves, not just the antibody. The biotinylated primary and the streptavidin conjugate both need titrating, and an excess of either raises background. Amplification multiplies the background as faithfully as the signal.

Choosing between streptavidin and avidin conjugates

Streptavidin is bacterial, unglycosylated and near neutral in charge, which gives it lower non-specific binding than avidin in most tissues. Avidin is cheaper and its glycosylation and positive charge cause background in some samples.

For blocking endogenous biotin, avidin followed by free biotin is the classic sequence and it works precisely because avidin binds tissue biotin strongly. Use the streptavidin conjugate for detection and avidin for blocking.

Where the amplification is not worth it

For an abundant target, a directly conjugated antibody gives cleaner data with fewer steps and better quantitative behaviour. Amplification systems compress the relationship between amount and signal, which makes quantitation harder.

For multiplexing, every biotinylated reagent competes for the same streptavidin, so only one biotinylated primary can be used per sequential step. Panels needing several amplified markers become long protocols quickly.

Making your own conjugate

Amine reactive biotinylation kits are straightforward, and the two things that go wrong are a buffer containing a primary amine and a carrier protein in a stabilised antibody preparation, either of which is labelled in preference to the antibody.

Measure the biotin to protein ratio afterwards and titrate the result. Over-biotinylation raises background and can impair binding, and both are avoidable by measuring rather than assuming.

Common questions

When should I use a biotinylated antibody?

When signal is the limitation and a directly conjugated reagent is not sensitive enough. The biotin and streptavidin system amplifies at two stages and is the standard route for low abundance targets in tissue.

What is endogenous biotin and why does it matter?

Biotin present naturally in tissues, particularly liver, kidney and brain. It binds the streptavidin conjugate directly, so those tissues stain with no primary antibody at all. Blocking with avidin then free biotin prevents it.

Does a biotin labeled antibody work in flow cytometry?

Yes, with a streptavidin conjugate as the second step, and it is a common way to build a panel where a needed clone is not available in the fluorophore you want. It adds a wash step and requires its own titration.

Can biotin in a sample interfere with an immunoassay?

It can. High biotin intake raises circulating biotin enough to interfere with assays built on this system, which is a documented cause of erroneous clinical results and a reason to ask what a sample donor was taking.

Browse by service class

• Compare Gene synthesis on advertised prices